METHOD FOR TREATING GENITAL FISTULAS

FIELD: medicine, gynecology, surgery. ^ SUBSTANCE: one should introduce 3.5%-chitosan ascorbate gel into fistulous channel that contains metronidasol at the dosage of 2 mg/ml, at the volume up to 20 ml once/2 d till complete fistula's closing. The present innovation enables to activate reparati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MAR'JANCHIK IRINA DMITRIEVNA, KOSHEUTOVA NATAL'JA VIKTOROVNA, TSKHAJ VITALIJ BORISOVICH, FADEEVA ELENA KONSTANTINOVNA, ERMOSHKIN OLEG ALEKSANDROVICH, NASIBOV SULEJMAN MADATOVICH, BOL'SHAKOV IGOR' NIKOLAEVICH, POLJANSKAJA RIMMA TIMOFEEVNA
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, gynecology, surgery. ^ SUBSTANCE: one should introduce 3.5%-chitosan ascorbate gel into fistulous channel that contains metronidasol at the dosage of 2 mg/ml, at the volume up to 20 ml once/2 d till complete fistula's closing. The present innovation enables to activate reparative processes and fistulous epithelization that favors for closing fistulous channel in earlier terms. ^ EFFECT: higher efficiency of therapy conducted. ^ 2 ex